Cryptococcus neoformans capsular polysaccharides form branched and complex filamentous networks viewed by high-resolution microscopy

被引:17
作者
Araujo, Glauber R. de S. [1 ,2 ]
Fontes, Giselle N. [2 ]
Leao, Daniela [2 ]
Rocha, Gustavo Miranda [1 ]
Pontes, Bruno [3 ]
Sant'Anna, Celso [2 ]
de Souza, Wanderley [1 ,2 ]
Frases, Susana [1 ,2 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941902 Rio De Janeiro, Brazil
[2] Natl Inst Metrol Qual & Technol Inmetro, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Pincas Ot COPEA, BR-21941902 Rio De Janeiro, Brazil
关键词
C; neoformans; Fungal virulence; Capsule; Polysaccharide; Electron microscopy; MONOCLONAL-ANTIBODIES; GLUCURONOXYLOMANNAN; SEROTYPE; BIOSYNTHESIS; AMYLOPECTIN; BINDING; YEAST; GALACTOXYLOMANNAN; ARCHITECTURE; CORRELATE;
D O I
10.1016/j.jsb.2015.11.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cryptococcus neoformans is a fungal pathogen that causes life-threatening infections in immunocompromised individuals. Its main virulence factor is an extracellular polysaccharide capsule whose structure, assembly and dynamics remain poorly understood. In this study, we apply improved protocols for sample preparation and recently-developed scanning microscopy techniques to visualize the ultrastructure of the C. neoformans capsule at high-resolution (up to 1 nm) and improved structural preservation. Although most capsule structures in nature consist of linear polymers, we show here that the C. neoformans capsule is a 'microgel-like' structure composed of branched polysaccharides. Moreover, we imaged the capsule-to-cell wall link, which is formed by thin fibers that branch out of thicker capsule filaments, and have one end firmly embedded in the cell wall structure. Together, our findings provide compelling ultrastructural evidence for a branched and complex capsule conformation, which may have important implications for the biological activity of the capsule as a virulence factor. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 66 条
[1]   CONFORMATIONAL CONTRIBUTIONS OF AMYLOSE AND AMYLOPECTIN TO THE STRUCTURAL-PROPERTIES OF STARCHES FROM VARIOUS SOURCES [J].
ABERLE, T ;
BURCHARD, W ;
VORWERG, W ;
RADOSTA, S .
STARCH-STARKE, 1994, 46 (09) :329-335
[2]   Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells [J].
Araujo, Glauber de S. ;
Fonseca, Fernanda L. ;
Pontes, Bruno ;
Torres, Andre ;
Cordero, Radames J. B. ;
Zancope-Oliveira, Rosely M. ;
Casadevall, Arturo ;
Viana, Nathan B. ;
Nimrichter, Leonardo ;
Rodrigues, Marcio L. ;
Garcia, Eloi S. ;
de Souza, Wanderley ;
Frases, Susana .
PLOS ONE, 2012, 7 (01)
[3]   Laser light scattering of high amylose and high amylopectin materials, stability in water after microwave dispersion [J].
Bello-Pérez, LA ;
Roger, P ;
Colonna, P ;
Paredes-López, O .
CARBOHYDRATE POLYMERS, 1998, 37 (04) :383-394
[4]   Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans [J].
Bryan, RA ;
Zaragoza, O ;
Zhang, T ;
Ortiz, G ;
Casadevall, A ;
Dadachova, E .
EUKARYOTIC CELL, 2005, 4 (02) :465-475
[5]   Passive antibody therapy for infectious diseases [J].
Casadevall, A ;
Dadachova, E ;
Pirofski, L .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (09) :695-703
[6]   Melanin and virulence in Cryptococcus neoformans [J].
Casadevall, A ;
Rosas, AL ;
Nosanchuk, JD .
CURRENT OPINION IN MICROBIOLOGY, 2000, 3 (04) :354-358
[7]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241
[8]   WALL STRUCTURE AND BUD FORMATION IN CRYPTOCOCCUS-NEOFORMANS [J].
CASSONE, A ;
SIMONETTI, N ;
STRIPPOLI, V .
ARCHIVES OF MICROBIOLOGY, 1974, 95 (03) :205-212
[9]   Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier [J].
Charlier, C ;
Chrétien, F ;
Baudrimont, M ;
Mordelet, E ;
Lortholary, O ;
Dromer, F .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :421-432
[10]  
Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146